Trials / Completed
CompletedNCT05259995
Sustained Acoustic Medicine Ultrasound Diathermy Clinical Performance
Verification of Performance of Sustained Acoustic Medicine Device Designs Diathermy
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 54 (actual)
- Sponsor
- ZetrOZ, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to measure diathermy performance of Sustained Acoustic Medicine Devices with commercially available ultrasound gel coupling patches.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Sustained Acoustic Medicine | The SAM device emits continuous ultrasound at 3 megahertz (MHz) frequency and 0.132 watts/cm2 intensity delivering 18,720 Joules of ultrasound per 4 hour treatment. |
Timeline
- Start date
- 2022-02-21
- Primary completion
- 2022-06-30
- Completion
- 2022-06-30
- First posted
- 2022-03-02
- Last updated
- 2023-02-21
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05259995. Inclusion in this directory is not an endorsement.